4.6 Article

Effect of time to relapse on overall survival in patients with mantle cell lymphoma following autologous haematopoietic cell transplantation

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Hematology

Cellular Therapies for Mantle Cell Lymphoma

Farah Yassine et al.

Summary: MCL is a subtype of B cell non-Hodgkin lymphoma with treatment options including autologous hematopoietic cell transplant, allogeneic HCT, and CAR T therapy. Recently, CAR T therapy has been approved by the US FDA for the treatment of MCL.

TRANSPLANTATION AND CELLULAR THERAPY (2021)

Article Hematology

Detailed Long-Term Follow-Up of Patients Who Relapsed After the Nordic Mantle Cell Lymphoma Trials: MCL2 and MCL3

Christian Winther Eskelund et al.

Summary: In patients with mantle cell lymphoma, early disease progression (POD24) significantly affects survival, and other biomarkers have independent prognostic value. Novel therapies are particularly important for patients with high-risk features.

HEMASPHERE (2021)

Meeting Abstract Hematology

Outcomes Following Early Relapse in Patients with Mantle Cell Lymphoma

David A. Bond et al.

Article Mathematics, Interdisciplinary Applications

Dynamic predicting by landmarking as an alternative for multi-state modeling: an application to acute lymphoid leukemia data

Hans C. van Houwelingen et al.

LIFETIME DATA ANALYSIS (2008)

Article Computer Science, Interdisciplinary Applications

A SAS macro for estimation of direct adjusted survival curves based on a stratified Cox regression model

Xu Zhang et al.

COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE (2007)

Article Oncology

Revised response criteria for malignant lymphoma

Bruce D. Cheson et al.

JOURNAL OF CLINICAL ONCOLOGY (2007)